The addition of RARP to ADT significantly increased the rate of achieving radical level PSA levels (74.7% vs 38.3%; P <.001) and a shorter time to PSA nadir (2 vs 6 months; P <.001) compared with ADT ...

Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...

Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.

MRI is the ideal imaging modality for initial evaluation and diagnosis of testicular cancer.

Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use.

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

The FDA has approved Akeega plus prednisone for adults with deleterious BRCA2-mutated metastatic castration-sensitive prostate cancer.

Quality improvement initiative sought to optimize surgical preference cards for urology, colorectal, and surgical oncology services.

Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM.

Investigators compared PSA90 response between new users of apalutamide vs abiraterone for mCSPC using a large US cohort.